12. 01. 2021

New diversity data from Phesi shows inclusion of Black and African American patients in clinical trials improving, but Asian, Hispanic and Latino groups significantly and consistently underrepresented

By analyzing protocol design data from Phase 2 and 3 clinical trials conducted in the United States only between year 2010 and 2020, Phesi showed that Asian, Hispanic and Latino, Native Americans and Alaska natives, Native Hawaiians and other Pacific Islander patient subpopulations were all significantly and consistently underrepresented over the decade.

Read more